Immune and Metabolic Gene Networks

"Immune and metabolic gene networks" refers to interconnected sets of genes whose products coordinate the regulation of immune responses and metabolic processes[1][2][3][4][7][9]. These networks are studied to understand how genetic perturbations, environmental triggers, or disease processes such as inflammation or metabolic disorders alter system-level biology. They help researchers discover regulatory genes, disease susceptibility modules, and potential new therapeutic targets, especially in complex disorders where both immunity and metabolism are dysregulated (e.g., inflammatory bowel disease, obesity, psoriasis, and metabolic syndrome)[1][2][3][6][7][9]. Network biology or systems genomics approaches are most commonly used to analyze these gene sets, rather than targeting them with drugs directly. As such, "immune and metabolic gene networks" is a conceptual and analytic framework, not a discrete receptor, enzyme, or other canonical drug target. Summary of key issues: - This is *not* a single molecule, receptor, or druggable target. - It should not be included in lists of therapeutic targets as a canonical entity. - Structured target information (e.g., drug interactions, mechanisms) is not applicable for the network as a whole; such detail is found at the level of individual genes within these networks[1][3][4][5][6][7][9].